Who invested in SutroVax?
SutroVax's investors include Longitude Capital, Abingworth, Frazier Healthcare Partners, Roche Venture Fund and CTI Life Sciences Fund, and 10 more on record.
United States · Series C startup
3 rounds we have observed, with the 15 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$167Mraised across 3 rounds since 2015, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $43M sold, first sale May 2018
Reported by FinSMEsSEC filing: $40M sold, first sale Mar 2017
From a historical funding recordSEC filing: $13M sold, first sale Jul 2015
From the SEC filings it signed: 4 on the team.
On the board, as filediHeath J LukatchKurt P von EmsterMoncef J SlaouiPatrick J EnrightPatrick J HeronPeter J HirthRob J HopfnerWilliam J Newell
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
SutroVax's investors include Longitude Capital, Abingworth, Frazier Healthcare Partners, Roche Venture Fund and CTI Life Sciences Fund, and 10 more on record.
SutroVax has raised $167M across 3 rounds since 2015.
SutroVax's most recent round was a Series C of $85M in Jun 2018.
Its most recent round, $85M in Jun 2018, is also its largest on record.
SutroVax's first round on record, in Jul 2015, was backed by Longitude Capital, Abingworth and Roche Venture Fund and 1 others.
SutroVax's latest named round is a Series C, in Jun 2018.
SutroVax is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.